@article{9365bfe4a4924959a43913a74f34cde5,
title = "Insights from nanomedicine into chloroquine efficacy against COVID-19",
keywords = "Antiviral Agents/pharmacokinetics, Betacoronavirus, Chloroquine/pharmacokinetics, Coronavirus Infections/drug therapy, Endocytosis/drug effects, Humans, Hydrogen-Ion Concentration, Hydroxychloroquine/pharmacokinetics, Inflammation, Nanomedicine, Nanoparticles, Pandemics, Pneumonia, Viral/drug therapy, Spike Glycoprotein, Coronavirus/drug effects, Virion/drug effects, Virus Replication/drug effects",
author = "Hu, {Tony Y.} and Matthew Frieman and Joy Wolfram",
note = "Funding Information: We acknowledge funding in the area of namomedicine for infectious disease research from the following sources: the Department of Defense under award number DODW8IXWH1910926 (T.Y.H.) and the National Institutes of Health under award numbers R01HD090927 (T.Y.H.), R01AI122932 (T.Y.H.), R01AI113725 (T.Y.H.), R21AI126361 (T.Y.H.), R21EB026347 (T.Y.H.) and R21AI52318 (J.W.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the funding agencies.",
year = "2020",
month = apr,
day = "1",
doi = "10.1038/s41565-020-0674-9",
language = "English (US)",
volume = "15",
pages = "247--249",
journal = "Nature Nanotechnology",
issn = "1748-3387",
publisher = "Nature Publishing Group",
number = "4",
}